ICG writes €500m cheque for medical single-asset deal
ICG underwrote nearly half the transaction on Curium Pharma, an asset described as 'cream of the crop' by one secondaries buyer.
ICG underwrote nearly half the transaction on Curium Pharma, an asset described as 'cream of the crop' by one secondaries buyer.
Copyright PEI Media
Not for publication, email or dissemination